As of 2025-05-15, the Intrinsic Value of Iovance Biotherapeutics Inc (IOVA) is (51.00) USD. This IOVA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.76 USD, the upside of Iovance Biotherapeutics Inc is -2997.8%.

The range of the Intrinsic Value is (112.12) - (34.83) USD.

Is IOVA undervalued or overvalued?

Based on its market price of 1.76 USD and our intrinsic valuation, Iovance Biotherapeutics Inc (IOVA) is overvalued by 2997.8%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

1.76 USD

Stock Price

(51.00) USD

Intrinsic Value

Intrinsic Value Details

IOVA Intrinsic Value - Valuation Summary

	Range	Selected	Upside
a
DCF (Growth Exit 5Y)	(112.12) - (34.83)	(51.00)	-2997.8%
Peter Lynch Fair Value	-5.57 - -5.57	-5.57	-416.63%
P/E Multiples	(17.28) - (22.00)	(17.33)	-1084.7%
EV/EBITDA Multiples	(15.28) - (12.98)	(15.69)	-991.3%

IOVA Intrinsic Value - Peers Comparison

	Range	Selected	Upside
a
Abbvie Inc	47.68 - 344.2	97.88	-46.1%
Amgen Inc	184.37 - 688.25	311.28	14.6%
Gilead Sciences Inc	18.4 - 82.16	33.75	-66.4%
Regeneron Pharmaceuticals Inc	446.41 - 919.64	592.59	1.3%
Halozyme Therapeutics Inc	48.21 - 100.64	65.53	33.9%
Amicus Therapeutics Inc	(0.09) - 1.35	0.22	-96.3%

IOVA Intrinsic Value - Key Valuation Metrics

Market Cap (mil)	588
Beta	1.73
Outstanding shares (mil)	334
Enterprise Value (mil)	473

Market risk premium	5.1%
Cost of Equity	8.05%
Cost of Debt	5%
WACC	8.0%